// App-Quantinova.ai

3036.0 : In vitro and in vivo characterization of MDNA11: A long-acting “beta-only” IL-2 superkine in syngeneic mice tumor models and nonhuman primates.

Researchers

Presenter

  • Moutih Rafei

Principal Investigators

  • Minh To

  • Fahar Merchant

  • Nina Merchant

Medical Centers

  • University of Montreal, Montreal, QC, Canada

  • Medicenna Therapeutics Inc, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Interleukin-2

Drug/Treatment

  • MDNA11

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved